Skip to content

Dr. Lieselot Decock

Active
Private limited companyfounded 20179 yrs activeStationsstraat 29D, 8650 Houthulst, BelgiumKBO/BCE: BE 0680.625.541

Dr. Lieselot Decock has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €364k and a net result of €121k. Equity is growing by ~45.9% per year across the filed fiscal years. Its solvency ranks better than 37% of 16459 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
91 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability88▲+5
Solvency72▲+12
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 3.74 against 2.68 in 2024; short-term debt: 17.6% and cash: 51.7% of total assets), but 53.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
46.8%
Return on assets
15.6%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 23-03-2026, 38 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
38 d early
2024
29 d early
2023
20 d early
2022
17 d early
2021
30 d early
2020
24 d early
2019
38 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
18-09-2026 today30-09-2026 close30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€364k▲ 50.0%
2024 · €242k
2018: €13k 2019: €27k 2020: €29k 2021: €89k 2022: €128k 2023: €187k 2024: €242k
2018 → 2025
Total assets
€776k▲ 12.1%
2024 · €692k
2018: €480k 2019: €504k 2020: €491k 2021: €545k 2022: €596k 2023: €638k 2024: €692k
2018 → 2025
Net result
€121k▲ 52.1%
2024 · €80k
2018: €161 2019: €15k 2020: €3k 2021: €55k 2022: €60k 2023: €61k 2024: €80k
2018 → 2025
Working capital
€374k▲ 48.1%
2024 · €253k
2018: €19k 2019: €41k 2020: €52k 2021: €117k 2022: €136k 2023: €196k 2024: €253k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€89k-€128k▲ 43.4%€187k▲ 46.8%€242k▲ 29.3%€364k▲ 50.0%
Operating result€78k-€80k▲ 2.8%€94k▲ 17.6%€108k▲ 14.7%€177k▲ 63.5%
Net result€55k-€60k▲ 9.1%€61k▲ 1.8%€80k▲ 31.4%€121k▲ 52.1%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150k€200kOperating result 2021: €78k€78kNet result 2021: €55k€55kOperating result 2022: €80k€80kNet result 2022: €60k€60kOperating result 2023: €94k€94kNet result 2023: €61k€61kOperating result 2024: €108k€108kNet result 2024: €80k€80kOperating result 2025: €177k€177kNet result 2025: €121k€121k20212022202320242025
The operating result has risen four years in a row; 2025 is 64% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €776k
Fixed assets €266k▼ 8.2%
Current assets €510k▲ 26.7%
Equity and liabilities €776k
Equity €364k▲ 50.0%
Debt €413k▼ 8.3%
The debt ratio falls from 65.0% to 53.2%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€200k
2024 · €134k
Cash flow
€145k
2024 · €106k
Solvency
46.8%
2024 · 35.0%
Current ratio
3.74
2024 · 2.68
Quick ratio
3.74
2024 · 2.68
Debt / equity
1.14
2024 · 1.86
ROE
33.4%
2024 · 32.9%
ROA
15.6%
2024 · 11.5%
Interest coverage
15.98
2024 · 9.79
Debt
€413k
2024 · €450k
Debt ≤ 1 year
€136k
2024 · €150k
Debt > 1 year
€270k
2024 · €292k
Income taxes
€44k
2024 · €15k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€692k€776k
Fixed assets21/28€290k€266k
Tangible fixed assets22/27€290k€266k
Plant, machinery and equipment23€18k€12k
Furniture and vehicles24€2k€1k
Other tangible fixed assets26€270k€253k
Current assets29/58€403k€510k
Amounts receivable within one year40/41€14k€107k
Other amounts receivable41€14k€107k
Cash at bank and in hand54/58€377k€401k
Deferred charges and accrued income490/1€11k€2k
Equity and liabilities
Total equity and liabilities10/49€692k€776k
Equity10/15€242k€364k
Contributions10/11€19k€19k=
Reserves13€200k€200k=
Distributable reserves133€200k€200k=
Profit (loss) carried forward14€24k€145k
Amounts payable17/49€450k€413k
Amounts payable after more than one year17€292k€270k
Financial debts170/4€292k€270k
Amounts payable within one year42/48€150k€136k
Current portion of amounts payable after more than one year42€23k€23k=
Trade debts44€5k€4k
Suppliers440/4€5k€4k
Taxes, remuneration and social security45€2k€17k
Taxes450/3€2k€17k
Other amounts payable47/48€121k€92k
Accrued charges and deferred income492/3€7k€7k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€26k€24k
Other operating charges640/8€3k€3k
Gross operating margin9900€137k€203k
Operating profit (loss)9901€108k€177k
Financial income75/76B€498€508
Recurring financial income75€498€508
Financial charges65/66B€14k€13k
Recurring financial charges65€14k€13k
Profit (loss) for the period before taxes9903€95k€165k
Income taxes67/77€15k€44k
Profit (loss) for the period9904€80k€121k
Profit (loss) for the period to be appropriated9905€80k€121k
Appropriation of the result
Profit (loss) to be appropriated9906€107k€145k
Profit (loss) brought forward from the previous period14P€27k€24k
Transfer to equity691/2€58k-
To other reserves6921€58k-
Profit to be distributed694/7€25k-
Return on contributions (dividend)694€860-
Directors or managers695€24k-

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 30-04-2027
2026
23-03
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial Highest result since 2018net €121k ▲52.1%
Operating result €177k, net result €121k, both a record.
01-04
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
30-09
Financial Equity above €200kEq €242k ▲29.3%
7 profitable years in a row build equity to €242k.
10-04
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-09
Financial Equity above €150kEq €187k ▲46.8%
6 profitable years in a row build equity to €187k.
13-04
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-09
Financial Equity above €100kEq €128k ▲43.4%
5 profitable years in a row build equity to €128k.
31-03
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
06-04
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
23-03
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
10-04
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Houthulst · 1 establishment unit since 2017
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Stationsstraat 29D8650 Houthulst
Ground area
127 m²
Building footprint
66 m²
Volume, LiDAR
387 m³
Parcel 32015B0854/00B004, Flanders · tallest building 8.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Lieselot Decock
Stationsstraat 29D, 8650 HouthulstGeneral medical practice
since 20172.268.157.433
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
32015B0854/00B004 Flanders 127 m² 1 · 66 m² 8.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 9,120 companies in sector 86210 we hold annual accounts for 6,336. 5,127 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded01-09-2017
Fiscal year end30-09
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers

Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.